Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Wantao Wu
Observed name:
Wu, Wantao
Institutions:
Central South University,
Second Affiliated Hospital of Chongqing Medical University,
Xiangya Hospital Central South University,
Chongqing Medical University
Observed institutions:
Central South University,
China Pharmaceutical University,
Second Affiliated Hospital of Chongqing Medical University,
Hunan Cancer Hospital,
Xiangya Hospital Central South University,
State Key Laboratory of Natural Medicine,
Chongqing Medical University
show all 7
ORCID:
0009-0008-9501-2819
Observed ORCID:
0009-0008-9501-2819
OpenAlex ID:
A5033709255
Glioma targeted therapy: insight into future of molecular approaches
2022
·
Keyang Yang
, Zhijing Wu
, et al.
·
Molecular Cancer
·
708
PDF
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
2021
·
Hao Zhang
, Ziyu Dai
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
538
PDF
Patient-derived xenograft models in cancer therapy: technologies and applications
2023
·
Yihan Liu
, Wantao Wu
, et al.
·
Signal Transduction and Targeted Therapy
·
502
PDF
Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials
2023
·
Hao Zhang
, Xinghai Yue
, et al.
·
Molecular Cancer
·
428
PDF
Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts
2022
·
Yuchen Wang
, Hao Zhang
, et al.
·
Journal of Hematology & Oncology
·
257
The molecular feature of macrophages in tumor immune microenvironment of glioma patients
2021
·
Hao Zhang
, Yue-Bei Luo
, et al.
·
Computational and Structural Biotechnology Journal
·
146
PDF
Machine learning-based identification of tumor-infiltrating immune cell-associated lncRNAs for improving outcomes and immunotherapy responses in patients with low-grade glioma
2022
·
Nan Zhang
, Hao Zhang
, et al.
·
Theranostics
·
141
PDF
Machine learning-based tumor-infiltrating immune cell-associated lncRNAs for predicting prognosis and immunotherapy response in patients with glioblastoma
2022
·
Hao Zhang
, Nan Zhang
, et al.
·
Briefings in Bioinformatics
·
83
Intratumor heterogeneity: the hidden barrier to immunotherapy against MSI tumors from the perspective of IFN-γ signaling and tumor-infiltrating lymphocytes
2021
·
Wantao Wu
, Yihan Liu
, et al.
·
Journal of Hematology & Oncology
·
82
B2M overexpression correlates with malignancy and immune signatures in human gliomas
2021
·
Hao Zhang
, Biqi Cui
, et al.
·
Scientific Reports
·
78
PDF
Beyond the Gut: The intratumoral microbiome's influence on tumorigenesis and treatment response
2024
·
Hao Zhang
, Li Fu
, et al.
·
癌症:英文版
·
70
An artificial intelligence network‐guided signature for predicting outcome and immunotherapy response in lung adenocarcinoma patients based on 26 machine learning algorithms
2023
·
Nan Zhang
, Hao Zhang
, et al.
·
Cell Proliferation
·
69
PTX3 mediates the infiltration, migration, and inflammation‐resolving‐polarization of macrophages in glioblastoma
2022
·
Hao Zhang
, Yifan Wang
, et al.
·
CNS Neuroscience & Therapeutics
·
51
The Predictive Value of Monocytes in Immune Microenvironment and Prognosis of Glioma Patients Based on Machine Learning
2021
·
Nan Zhang
, Ziyu Dai
, et al.
·
Frontiers in Immunology
·
49
PDF
Molecular insight into pentraxin-3: Update advances in innate immunity, inflammation, tissue remodeling, diseases, and drug role
2022
·
Hao Zhang
, Ruixuan Wang
, et al.
·
Biomedicine & Pharmacotherapy
·
48
PDF
Decoding the metabolic dialogue in the tumor microenvironment: from immune suppression to precision cancer therapies
2025
·
Ruoli Wang
, Jincheng Zhuang
, et al.
·
Experimental Hematology and Oncology
·
46
PDF
Large-Scale Single-Cell and Bulk Sequencing Analyses Reveal the Prognostic Value and Immune Aspects of CD147 in Pan-Cancer
2022
·
Jingwei Zhang
, Zeyu Wang
, et al.
·
Frontiers in Immunology
·
46
Comprehensive molecular classification predicted microenvironment profiles and therapy response for HCC
2024
·
Yihong Chen
, Xiangying Deng
, et al.
·
Hepatology
·
43
Novel Immune Infiltrating Cell Signature Based on Cell Pair Algorithm Is a Prognostic Marker in Cancer
2021
·
Hao Zhang
, Zeyu Wang
, et al.
·
Frontiers in Immunology
·
40
TNFSF13 Is a Novel Onco-Inflammatory Marker and Correlates With Immune Infiltration in Gliomas
2021
·
Rui Chen
, Xinxing Wang
, et al.
·
Frontiers in Immunology
·
39
PDF
A Pan-Cancer Analysis Reveals CLEC5A as a Biomarker for Cancer Immunity and Prognosis
2022
·
Rui Chen
, Wantao Wu
, et al.
·
Frontiers in Immunology
·
27
Uncovering the predictive and immunomodulatory potential of transient receptor potential melastatin family-related CCNE1 in pan-cancer
2024
·
Nan Zhang
, Hao Zhang
, et al.
·
Molecular Cancer
·
23
The tertiary lymphoid structure-related signature identified PTGDS in regulating PD-L1 and promoting the proliferation and migration of glioblastoma
2023
·
Wantao Wu
, He Li
, et al.
·
Heliyon
·
23
Identify the immune characteristics and immunotherapy value of CD93 in the pan-cancer based on the public data sets
2022
·
Aiyuan Guo
, Jingwei Zhang
, et al.
·
Frontiers in Immunology
·
21
Endoplasmic reticulum stress in disease pathogenesis: its implications for therapy
2026
·
Siyu Wei
, Nan Zhang
, et al.
·
Signal Transduction and Targeted Therapy
·
20
PDF
Show more works
View as search
Works count:
65
Citation count:
3,867
H-index:
23
I10-index:
40
Year
Topic
Type